Specialty chemicals maker Albemarle Corporation , a leading global manufacturer of the anti-inflammatory agent ibuprofen and other active pharmaceutical ingredients (APIs), has signed a global agreement with pharmaceutical company Dr. Reddy's Laboratories Ltd. As per the agreement, effective immediately, Albemarle has appointed Dr. Reddy's as a non-exclusive distributor of Albemarle's bulk ibuprofen API. As part of the agreement, Dr. Reddy's will market, sell and distribute Albemarle's ibuprofen API to Dr. Reddy's global client base. In addition, Albemarle will also supply Dr. Reddy's a substantial quantity of its ibuprofen API requirements for use in the company's generic ibuprofen tablets.
The details can be read here.
No comments:
Post a Comment